- Home
- SIDU vs MYNZ Comparison
SIDU vs MYNZ Comparison
Compare SIDU & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIDU | MYNZ |
|---|---|---|
| Founded | 2012 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.1M | 8.8M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SIDU | MYNZ |
|---|---|---|
| Price | $3.65 | $1.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 59.5M | 200.2K |
| Earning Date | 11-14-2025 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,623,538.00 | $659,935.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $100.00 | $5.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $0.92 |
| 52 Week High | $6.75 | $8.20 |
Technical Indicators
Market Signals| Indicator | SIDU | MYNZ |
|---|---|---|
| Relative Strength Index (RSI) | 74.27 | 46.89 |
| Support Level | $1.77 | $1.09 |
| Resistance Level | $3.38 | $1.35 |
| Average True Range (ATR) | 0.52 | 0.10 |
| MACD | 0.21 | 0.02 |
| Stochastic Oscillator | 72.33 | 38.03 |
Price Performance
Historical ComparisonAbout SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.